Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nevro Corp (NVRO)

Nevro Corp (NVRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Nevro: Q3 Earnings Snapshot

Nevro: Q3 Earnings Snapshot

NVRO : 4.52 (+11.06%)
Nevro: Q2 Earnings Snapshot

Nevro: Q2 Earnings Snapshot

NVRO : 4.52 (+11.06%)
Nevro: Q1 Earnings Snapshot

Nevro: Q1 Earnings Snapshot

NVRO : 4.52 (+11.06%)
Why Nevro Stock Lagged the Market on Thursday

Despite convincing beats on its latest set of quarterly figures, the market wasn't all that impressed with the company's latest developments.

NVRO : 4.52 (+11.06%)
Nevro: Q4 Earnings Snapshot

Nevro: Q4 Earnings Snapshot

NVRO : 4.52 (+11.06%)
Nevro: Q3 Earnings Snapshot

Nevro: Q3 Earnings Snapshot

NVRO : 4.52 (+11.06%)
Nevro to Report Third Quarter 2023 Financial Results

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 4.52 (+11.06%)
New Data Demonstrate the Health Economic Benefits of Nevro's High-Frequency Spinal Cord Stimulation Therapy

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 4.52 (+11.06%)
Nevro Announces Participation in Upcoming Investor Conferences

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain,...

NVRO : 4.52 (+11.06%)
New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain,...

NVRO : 4.52 (+11.06%)

Barchart Exclusives

Skip the VIX, Buy This Dividend Stock to Profit from Volatility
Instead of trying to profit from market volatility through traditional means like the VIX, investors may want to consider buying shares of Cboe Global Markets, the company behind the VIX. Cboe Global Markets is well-positioned to benefit from rising demand for derivatives trading and offers a solid dividend yield. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar